共 173 条
[51]
Diekamp S(2007)Exploiting signal transduction pathways in acute myelogenous leukemia Curr Treat Options Oncol 8 265-276
[52]
Langebrake C(2007)Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia Curr Treat Options Oncol 8 277-286
[53]
Grimwade D(2004)Determinants of antileukemia effects of allogeneic NK cells J Immunol 172 644-650
[54]
Walker H(2002)Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2097-2100
[55]
Oliver F(2003)Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 102 814-819
[56]
Appelbaum F(2005)Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes Blood 105 4878-4884
[57]
Kopecky KJ(2007)Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT Blood 109 5058-5061
[58]
Tallman M(2007)Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: Challenging its predictive value Blood 110 433-440
[59]
Rubnitz JE(2005)Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors J␣Immunol 174 6540-6545
[60]
Raimondi SC(2005)Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 105 3051-3057